GridAI Technologies GRDX
NASDAQ GRDX
$2.95 -0.07 (-2.16%)
As of: Sep 10, 2026 · 3:09 PM EDT

GridAI Technologies (GRDX) Payables (2015 - 2026)

GridAI Technologies' (GRDX) quarterly Payables came in at $5.8 million in Q2 2026, up 67.0% on a YoY basis from $3.5 million in Q2 2025, and down 18.07% quarter-over-quarter from $7.1 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Payables (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Payables for 12 consecutive years, with $5.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Payables rose 67.0% year-over-year to $5.8 million; the trailing twelve-month figure through Jun 2026 stood at $5.8 million (up 67.0% YoY), and the FY2025 full-year result was $7.1 million, up 65.26% from the prior year.
  • Payables retreated to $5.8 million in Q2 2026 per GRDX's latest filing, from $7.1 million in the prior quarter.
  • Across five years, Payables topped out at $7.1 million in Q4 2025 and bottomed at $810338.0 in Q3 2023.
  • Historically, Payables has averaged $3.4 million across 5 years, with a median of $3.5 million in 2025.
  • The sharpest annual moves came in 2022 and 2024: Payables sank 79.5% in 2022, then surged 196.64% in 2024.
  • Over 5 years, Payables stood at $2.1 million in 2022, then advanced by 7.27% to $2.2 million in 2023, then jumped by 90.9% to $4.3 million in 2024, then surged by 65.26% to $7.1 million in 2025, then slipped by 18.07% to $5.8 million in 2026.
  • According to Business Quant data, Payables over the past three periods registered $5.8 million, $7.1 million, and $6.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Amgen 206.74 Bn 192.75 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 179.96 Bn 176.78 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 131.20 Bn 123.35 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 82.05 Bn 74.05 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 60.28 Bn 55.10 Bn 1.37 Bn 1.52 Bn
6 Moderna 53.67 Bn 48.54 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 33.08 Bn 29.78 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.91 Bn 30.62 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 29.22 Bn 29.22 Bn 1.16 Mn 25.08 Mn
10 GridAI Technologies 18.97 Mn 18.97 Mn -36,514.00 5.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.78 Mn
Dec 31, 2025 7.06 Mn
Sep 30, 2025 6.54 Mn
Jun 30, 2025 3.46 Mn
Mar 31, 2025 4.24 Mn
Dec 31, 2024 4.27 Mn
Sep 30, 2024 2.40 Mn
Jun 30, 2024 2.30 Mn
Mar 31, 2024 2.45 Mn
Dec 31, 2023 2.24 Mn
Sep 30, 2023 810,338.00
Jun 30, 2023 1.93 Mn
Mar 31, 2023 937,581.00
Dec 31, 2022 2.09 Mn
Sep 30, 2022 3.88 Mn
Jun 30, 2022 4.32 Mn
Mar 31, 2022 3.94 Mn
Dec 31, 2021 3.81 Mn
Sep 30, 2021 18.93 Mn
Jun 30, 2021 5.01 Mn